http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113597312-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_566f78499a30ed019d2f925286f64063 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a19b500d90fd0195413872dfd1a0ad |
| publicationDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113597312-A |
| titleOfInvention | Methods for improved immunotherapy |
| abstract | Methods of adoptive neuroimmunotherapy, selecting a subject suitable for adoptive neuroimmunotherapy, selecting a molecule or combination of molecules for increasing the potential of a therapeutic immune cell, and reducing the expression of PD-1 on the surface of an immune cell are provided, comprising contacting an immune cell with at least one molecule selected from a neurotransmitter or analog thereof, a neuropeptide or analog thereof, or a modulator of a voltage-gated ion channel. Kits comprising at least one of those molecules or comprising at least two of those molecules and optionally a PD-1 detection agent are also provided. |
| priorityDate | 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 195.